IDEAYA Biosciences (IDEAYA) is a developer of molecular therapies. It is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality medicines targeting DNA damage and repair for genetically defined patient populations; for enhancing immunotherapy response and immuno-oncology therapies targeting the tumour microenvironment.